SCHEMBL4924477

SCHEMBL4924477

O=C(Nc1ccc(-c2cnc(C(=O)[C@H]3CCC[C@@H]3C(=O)O)s2)cc1)Nc1cc(C(F)(F)F)ccc1F

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGAT1 O75907 12/20 0.72
RIPK1 Q13546 1/20 0.48
KDR P35968 6/20 0.47
KIT P10721 3/20 0.47
FLT1 P17948 3/20 0.47
PDGFRB P09619 2/20 0.47
LCK P06239 2/20 0.47
CSF1R P07333 2/20 0.47
FGFR1 P11362 2/20 0.47
FGFR3 P22607 2/20 0.47
FLT4 P35916 2/20 0.47
FLT3 P36888 2/20 0.47
TEK Q02763 2/20 0.47
PDGFRA P16234 1/20 0.47
FGFR2 P21802 1/20 0.47
FGFR4 P22455 1/20 0.47
PLK4 O00444 1/20 0.46
AURKA O14965 1/20 0.46
MAPK13 O15264 1/20 0.46
PDPK1 O15530 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4924491 1.00 DGAT1 (0.72) DGAT1RIPK1KDRKITFLT1
SCHEMBL4924483 1.00 DGAT1 (0.72) DGAT1RIPK1KDRKITFLT1
SCHEMBL4923400 0.97 DGAT1 (0.66) DGAT1RIPK1KDRKITFLT1
SCHEMBL4922387 0.92 DGAT1 (0.63) DGAT1KDR
SCHEMBL4922382 0.92 DGAT1 (0.63) DGAT1KDR
SCHEMBL4922391 0.92 DGAT1 (0.63) DGAT1KDR
SCHEMBL4911897 0.89 DGAT1 (0.57) DGAT1RIPK1KDRKITFLT1
SCHEMBL4924031 0.89 DGAT1 (0.57) DGAT1RIPK1KDRKITFLT1
SCHEMBL4911900 0.89 DGAT1 (0.57) DGAT1RIPK1KDRKITFLT1
SCHEMBL4914171 0.87 DGAT1 (0.60) DGAT1KDRKITFLT1LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080064717-A1 Inhibitors of diacylglycerol O-acyltransferase type 1 enzyme ABBOTT LABORATORIES 2008-03-13 US claimed
US-20080064717-A1 Inhibitors of diacylglycerol O-acyltransferase type 1 enzyme ABBOTT LABORATORIES 2008-03-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080064717-A1 Inhibitors of diacylglycerol O-acyltransferase type 1 enzyme DGAT1, DGAT2, DLAT DGAT1 1/4885RIPK1 3230/4885KDR 4607/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.